ADVAGEN Trademark

Trademark Overview


On Friday, January 5, 2024, a trademark application was filed for ADVAGEN with the United States Patent and Trademark Office. The USPTO has given the ADVAGEN trademark a serial number of 98344686. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Thursday, October 3, 2024. This trademark is owned by ADVAGEN PTE. LTD.. The ADVAGEN trademark is filed in the Pharmaceutical Products category with the following description:

Dietary Supplements; Nutritional Supplements; Cardiovascular pharmaceutical preparations; Pharmaceutical agents affecting metabolism; Digestives for pharmaceutical purposes; Dextrins for pharmaceutical use; Starch for pharmaceutical purposes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for suppressing tumors; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for treating allergic rhinitis; Pharmaceutical preparations for the treatment of hypercholesteremia; Pharmaceutical preparations for the prevention of osteoporosis; Pharmaceutical products for the treatment of cancer; Pharmaceutical preparations for the central nervous system; Plant extracts, other than essential oils, for pharmaceutical purposes; Plant extracts, other than essential oils, for medical, veterinary and pharmaceutical purposes; Pharmaceutical preparations for the treatment of infectious diseases; Ph...
advagen

General Information


Serial Number98344686
Word MarkADVAGEN
Filing DateFriday, January 5, 2024
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateThursday, October 3, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesDietary Supplements; Nutritional Supplements; Cardiovascular pharmaceutical preparations; Pharmaceutical agents affecting metabolism; Digestives for pharmaceutical purposes; Dextrins for pharmaceutical use; Starch for pharmaceutical purposes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for suppressing tumors; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for treating allergic rhinitis; Pharmaceutical preparations for the treatment of hypercholesteremia; Pharmaceutical preparations for the prevention of osteoporosis; Pharmaceutical products for the treatment of cancer; Pharmaceutical preparations for the central nervous system; Plant extracts, other than essential oils, for pharmaceutical purposes; Plant extracts, other than essential oils, for medical, veterinary and pharmaceutical purposes; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical products for the treatment of infectious diseases; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical preparations for the treatment of musculoskeletal disorders; Therapeutic pharmaceutical for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Vitamin and mineral supplements for use as ingredients in the food and pharmaceutical industry; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Chemical preparations for pharmaceutical or medical purposes, namely, for viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; Pharmaceutical preparations for the treatment of inflammatory disorders; Pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; All aforementioned goods not for use in parenteral nutrition, in International Class 005.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 5, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameADVAGEN PTE. LTD.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSingapore 408733
SG

Trademark Events


Event DateEvent Description
Friday, January 5, 2024NEW APPLICATION ENTERED
Tuesday, April 23, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 1, 2024NON-FINAL ACTION WRITTEN
Thursday, August 1, 2024NON-FINAL ACTION E-MAILED
Thursday, August 1, 2024ASSIGNED TO EXAMINER
Thursday, August 1, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, September 28, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, September 28, 2024NON-FINAL ACTION E-MAILED
Saturday, September 28, 2024NON-FINAL ACTION WRITTEN
Wednesday, October 2, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 2, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 3, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 5, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 5, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 6, 2024TEAS/EMAIL CORRESPONDENCE ENTERED